Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Apr;77(8):1321–1326. doi: 10.1038/bjc.1998.220

Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?

E Bouffet 1, F Doz 1, M C Demaille 1, P Tron 1, H Roche 1, D Plantaz 1, A Thyss 1, J L Stephan 1, O Lejars 1, E Sariban 1, M Buclon 1, J M Zücker 1, M Brunat-Mentigny 1, J L Bernard 1, J C Gentet 1
PMCID: PMC2150165  PMID: 9579840

Abstract

Early detection of relapse has been advocated to improve survival in children with recurrent medulloblastoma. However, the prognostic factors and the longer term outcome of these patients remains unclear. Pattern of recurrences were analysed in three consecutive protocols of the Société Française d'Oncologie Pédiatrique (1985-91). A uniform surveillance programme including repeated lumbar puncture combined with computerized tomography (CT) or magnetic resonance imaging (MRI) scan was applied for all registered patients. Forty-six out of 116 patients had progressive or recurrent disease. The median time from diagnosis to recurrence was 10.5 months and 76% relapses occurred during the first 2 years. Seventeen patients had asymptomatic relapses that were detected by the surveillance protocol. Forty-one patients were treated at time of progression. Twenty-three responded to salvage therapy and 11 achieved a second complete remission. The median survival time after progression was 5 months (<1-41 months), and only two patients remained alive at time of follow-up. Length of survival is primarily related to some specific patterns of relapse (time from diagnosis to recurrence, circumstances of relapse, extent of relapse) and to the response to salvage therapy. No evidence of long-term benefit appeared from any form of treatment.

Full text

PDF
1321

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashley D. M., Meier L., Kerby T., Zalduondo F. M., Friedman H. S., Gajjar A., Kun L., Duffner P. K., Smith S., Longee D. Response of recurrent medulloblastoma to low-dose oral etoposide. J Clin Oncol. 1996 Jun;14(6):1922–1927. doi: 10.1200/JCO.1996.14.6.1922. [DOI] [PubMed] [Google Scholar]
  2. Bailey C. C., Gnekow A., Wellek S., Jones M., Round C., Brown J., Phillips A., Neidhardt M. K. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol. 1995 Sep;25(3):166–178. doi: 10.1002/mpo.2950250303. [DOI] [PubMed] [Google Scholar]
  3. Chastagner P., Sommelet-Olive D., Kalifa C., Brunat-Mentigny M., Zucker J. M., Demeocq F., Baranzelli M. C., Tron P., Bergeron C., Pein F. Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP). Med Pediatr Oncol. 1993;21(1):49–53. doi: 10.1002/mpo.2950210110. [DOI] [PubMed] [Google Scholar]
  4. Dupuis-Girod S., Hartmann O., Benhamou E., Doz F., Mechinaud F., Bouffet E., Coze C., Kalifa C. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? J Neurooncol. 1996 Jan;27(1):87–98. doi: 10.1007/BF00146088. [DOI] [PubMed] [Google Scholar]
  5. Elson P. J., Witte R. S., Trump D. L. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res. 1988 Dec 15;48(24 Pt 1):7310–7313. [PubMed] [Google Scholar]
  6. Evans A. E., Jenkin R. D., Sposto R., Ortega J. A., Wilson C. B., Wara W., Ertel I. J., Kramer S., Chang C. H., Leikin S. L. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg. 1990 Apr;72(4):572–582. doi: 10.3171/jns.1990.72.4.0572. [DOI] [PubMed] [Google Scholar]
  7. Finlay J. L., Goins S. C. Brain tumors in children. III. Advances in chemotherapy. Am J Pediatr Hematol Oncol. 1987 Fall;9(3):264–271. [PubMed] [Google Scholar]
  8. Finlay J. L., Goldman S., Wong M. C., Cairo M., Garvin J., August C., Cohen B. H., Stanley P., Zimmerman R. A., Bostrom B. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group. J Clin Oncol. 1996 Sep;14(9):2495–2503. doi: 10.1200/JCO.1996.14.9.2495. [DOI] [PubMed] [Google Scholar]
  9. Friedman H. S., Kun L. E. More on surveillance of children with medulloblastoma. N Engl J Med. 1995 Jan 19;332(3):191–191. doi: 10.1056/NEJM199501193320316. [DOI] [PubMed] [Google Scholar]
  10. Gentet J. C., Bouffet E., Doz F., Tron P., Roche H., Thyss A., Plantaz D., Stephan J. L., Mottolese C., Ponvert D. Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study. J Neurosurg. 1995 Apr;82(4):608–614. doi: 10.3171/jns.1995.82.4.0608. [DOI] [PubMed] [Google Scholar]
  11. Gentet J. C., Doz F., Bouffet E., Plantaz D., Roché H., Tron P., Kalifa C., Mazingue F., Sariban E., Chastagner P. Carboplatin and VP 16 in medulloblastoma: a phase II Study of the French Society of Pediatric Oncology (SFOP). Med Pediatr Oncol. 1994;23(5):422–427. doi: 10.1002/mpo.2950230506. [DOI] [PubMed] [Google Scholar]
  12. Gnekow A. K. Recommendations of the Brain Tumor Subcommittee for the reporting of trials. SIOP Brain Tumor Subcommittee. International Society of Pediatric Oncology. Med Pediatr Oncol. 1995 Feb;24(2):104–108. doi: 10.1002/mpo.2950240209. [DOI] [PubMed] [Google Scholar]
  13. Grundy P., Breslow N., Green D. M., Sharples K., Evans A., D'Angio G. J. Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study. J Clin Oncol. 1989 May;7(5):638–647. doi: 10.1200/JCO.1989.7.5.638. [DOI] [PubMed] [Google Scholar]
  14. Halperin E. C., Friedman H. S. Is there a correlation between duration of presenting symptoms and stage of medulloblastoma at the time of diagnosis? Cancer. 1996 Aug 15;78(4):874–880. doi: 10.1002/(SICI)1097-0142(19960815)78:4<874::AID-CNCR26>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
  15. Kalifa C., Hartmann O., Demeocq F., Vassal G., Couanet D., Terrier-Lacombe M. J., Valteau D., Brugieres L., Lemerle J. High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. Bone Marrow Transplant. 1992 Apr;9(4):227–233. [PubMed] [Google Scholar]
  16. Kemshead J. T., Papanastassiou V., Coakham H. B., Pizer B. L. Monoclonal antibodies in the treatment of central nervous system malignancies. Eur J Cancer. 1992;28(2-3):511–513. doi: 10.1016/s0959-8049(05)80090-5. [DOI] [PubMed] [Google Scholar]
  17. Latchaw J. P., Hahn J. F., Moylan D. J., Humphries R., Mealey J., Jr Medulloblastoma. Period of risk reviewed. Cancer. 1985 Jan 1;55(1):186–189. doi: 10.1002/1097-0142(19850101)55:1<186::aid-cncr2820550129>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  18. Lefkowitz I. B., Packer R. J., Ryan S. G., Shah N., Alavi J., Rorke L. B., Sutton L. N., Schut L. Late recurrence of primitive neuroectodermal tumor/medulloblastoma. Cancer. 1988 Aug 15;62(4):826–830. doi: 10.1002/1097-0142(19880815)62:4<826::aid-cncr2820620431>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  19. Leivonen M. K., Kalima T. V. Prognostic factors associated with survival after breast cancer recurrence. Acta Oncol. 1991;30(5):583–586. doi: 10.3109/02841869109092422. [DOI] [PubMed] [Google Scholar]
  20. Mahoney D. H., Jr, Steuber C. P., Sandbach J. F., Fernbach D. J. Extraneural metastases from medulloblastoma: long-term survival after sequentially scheduled chemotherapy and radiotherapy. Med Pediatr Oncol. 1986;14(6):329–331. doi: 10.1002/mpo.2950140611. [DOI] [PubMed] [Google Scholar]
  21. Mahoney D. H., Jr, Strother D., Camitta B., Bowen T., Ghim T., Pick T., Wall D., Yu L., Shuster J. J., Friedman H. High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. J Clin Oncol. 1996 Feb;14(2):382–388. doi: 10.1200/JCO.1996.14.2.382. [DOI] [PubMed] [Google Scholar]
  22. Mendel E., Levy M. L., Raffel C., McComb J. G., Pikus H., Nelson M. D., Jr, Ganz W. Surveillance imaging in children with primitive neuroectodermal tumors. Neurosurgery. 1996 Apr;38(4):692–695. [PubMed] [Google Scholar]
  23. Miyagami M., Satoh K., Tsubokawa T. A long surviving case of recurrent medulloblastoma displaying effectiveness of ACNU/vincristine chemotherapy. J Neurooncol. 1994;18(1):41–47. doi: 10.1007/BF01324602. [DOI] [PubMed] [Google Scholar]
  24. Pendergrass T. W., Milstein J. M., Geyer J. R., Mulne A. F., Kosnik E. J., Morris J. D., Heideman R. L., Ruymann F. B., Stuntz J. T., Bleyer W. A. Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy. J Clin Oncol. 1987 Aug;5(8):1221–1231. doi: 10.1200/JCO.1987.5.8.1221. [DOI] [PubMed] [Google Scholar]
  25. Raffel C., Culver K., Kohn D., Nelson M., Siegel S., Gillis F., Link C. J., Villablanca J. G., Anderson W. F. Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Ther. 1994 Jul;5(7):863–890. doi: 10.1089/hum.1994.5.7-863. [DOI] [PubMed] [Google Scholar]
  26. Silverman C. L., Simpson J. R. Cerebellar medulloblastoma: the importance of posterior fossa dose to survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1982 Nov;8(11):1869–1876. doi: 10.1016/0360-3016(82)90443-6. [DOI] [PubMed] [Google Scholar]
  27. Steinbok P., Hentschel S., Cochrane D. D., Kestle J. R. Value of postoperative surveillance imaging in the management of children with some common brain tumors. J Neurosurg. 1996 May;84(5):726–732. doi: 10.3171/jns.1996.84.5.0726. [DOI] [PubMed] [Google Scholar]
  28. Torres C. F., Rebsamen S., Silber J. H., Sutton L. N., Bilaniuk L. T., Zimmerman R. A., Goldwein J. W., Phillips P. C., Lange B. J. Surveillance scanning of children with medulloblastoma. N Engl J Med. 1994 Mar 31;330(13):892–895. doi: 10.1056/NEJM199403313301303. [DOI] [PubMed] [Google Scholar]
  29. Wara W. M., Le Q. T., Sneed P. K., Larson D. A., Prados M. D., Levin V. A., Edwards M. S., Weil M. D. Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy. Int J Radiat Oncol Biol Phys. 1994 Oct 15;30(3):551–556. doi: 10.1016/0360-3016(92)90940-j. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES